Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B John

Showing results (461-470 of 612) with videos related to

Pageof 62
Sort By:
Circulation. Cardiovascular Quality and Outcomes|February 19, 2019
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart DiseaseWilliam S Weintraub, Pamela M Hartigan, G B John Mancini, et al.
The Canadian Journal of Cardiology|November 26, 2013
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateG B John Mancini, A Yashar Tashakkor, Steven Baker, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
The Canadian Journal of Cardiology|July 22, 2015
Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.)Andrew C T Ha, Narendra Singh, Jafna L Cox, et al.
Journal of the American College of Cardiology|December 16, 2017
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary SyndromesKrishnan Ramanathan, James G Abel, Julie E Park, et al.
Applied Biochemistry and Biotechnology|July 2, 2021
Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M<sup>pro</sup>: Bioinformatics ApproachKaushik Kumar Bharadwaj, Tanmay Sarkar, Arabinda Ghosh, et al.
Journal of the American College of Cardiology|November 3, 2018
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE TrialDavid J Maron, G B John Mancini, Pamela M Hartigan, et al.
American Journal of Preventive Cardiology|July 30, 2021
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiationDiana N Vikulova, Ilia S Skorniakov, Brendon Bitoiu, et al.
Human Reproduction (Oxford, England)|October 26, 2007
Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrheaTeresa D Gallardo, George B John, Karen Bradshaw, et al.
Internal Medicine Journal|October 24, 2009
Evidence-based management of heart failure in clinical practice: a review of device-based therapy useS Thavapalachandran, D P Leong, M K Stiles, et al.
Pageof 62

Showing results (461-470 of 612) with videos related to

Sort By:
Pageof 62
Circulation. Cardiovascular Quality and Outcomes|February 19, 2019
Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart DiseaseWilliam S Weintraub, Pamela M Hartigan, G B John Mancini, et al.
The Canadian Journal of Cardiology|November 26, 2013
Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateG B John Mancini, A Yashar Tashakkor, Steven Baker, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
The Canadian Journal of Cardiology|July 22, 2015
Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.)Andrew C T Ha, Narendra Singh, Jafna L Cox, et al.
Journal of the American College of Cardiology|December 16, 2017
Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary SyndromesKrishnan Ramanathan, James G Abel, Julie E Park, et al.
Applied Biochemistry and Biotechnology|July 2, 2021
Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M<sup>pro</sup>: Bioinformatics ApproachKaushik Kumar Bharadwaj, Tanmay Sarkar, Arabinda Ghosh, et al.
Journal of the American College of Cardiology|November 3, 2018
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE TrialDavid J Maron, G B John Mancini, Pamela M Hartigan, et al.
American Journal of Preventive Cardiology|July 30, 2021
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiationDiana N Vikulova, Ilia S Skorniakov, Brendon Bitoiu, et al.
Human Reproduction (Oxford, England)|October 26, 2007
Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrheaTeresa D Gallardo, George B John, Karen Bradshaw, et al.
Internal Medicine Journal|October 24, 2009
Evidence-based management of heart failure in clinical practice: a review of device-based therapy useS Thavapalachandran, D P Leong, M K Stiles, et al.
Pageof 62